Pfizer Total Non-Operating Income/Expense 2010-2024 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pfizer annual total non-operating income/expense for 2024 was $-4.388B, a 1876.58% increase from 2023.
Pfizer annual total non-operating income/expense for 2023 was $-0.222B, a 79.1% decline from 2022.
Pfizer annual total non-operating income/expense for 2022 was $-1.062B, a 121.77% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pfizer annual total non-operating income/expense for 2024 was $-4.388B, a 1876.58% increase from 2023.
Pfizer annual total non-operating income/expense for 2023 was $-0.222B, a 79.1% decline from 2022.
Pfizer annual total non-operating income/expense for 2022 was $-1.062B, a 121.77% decline from 2021.